Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma

Name: Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
License: Public Domain

Weill Medical College of Cornell University

ClinicalTrials.gov · Datasets · License: Public Domain

esophageal adenocarcinoma, gastric adenocarcinoma, gastroesophageal junction adenocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 245512
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.